Skinny Labels at the Supreme Court: Carving Out Room for Generics to Breathe
HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for...
Jeremiah Helm Comments On How Upcoming Supreme Court ‘Skinny Label’ Case Could Impact Hatch-Waxman Litigation
In interviews with Law360 and Life Sciences Intellectual Property Review, Knobbe Martens partner Jeremiah Helm offered insights into the Supreme Court’s decision to hear a petition of the Federal Circuit’s...
Carol Pitzel Cruz Comments in Law360 on Enablement Analysis in Pharmaceutical Patent Litigation
Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...